Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-Appendiceal peritoneal carcinomatosis from a prospective database

Journal of Surgical Oncology

Volumn 96, Issue 2, 2007, Pages 102-112

  Yan, Tristan D ^a   Zappa, Luis ^a   Edwards, Gary ^a   Alderman, Robert ^a   Marquardt, Christina E ^a   Sugarbaker, Paul H ^a,b  

^a WASHINGTON CANCER INSTITUTE   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Colorectal cancer; Cytoreduction; Gastric cancer; Morbidity and mortality; Ovarian cancer; Perioperative intraperitoneal chemotherapy; Peritonectomy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN C; PACLITAXEL;

ACCURACY; ADULT; ARTICLE; CANCER GRADING; CANCER PATIENT; CARCINOMATOUS PERITONITIS; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CYTOREDUCTIVE SURGERY; DATA BASE; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; INTRAVENOUS CATHETER; LENGTH OF STAY; LUNG COMPLICATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEUROLOGICAL COMPLICATION; PERIOPERATIVE PERIOD; PERITONECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL MORTALITY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE;

CARCINOMA; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MORBIDITY; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERIOPERATIVE CARE; PERITONEAL NEOPLASMS; PERITONEUM; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34547927571     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20736     Document Type: Article

References (29)

1. Sugarbaker PH: New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 2006;7:69-76.
2. Sugarbaker PH, Yan TD, Stuart OA, et al.: Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol 2006;32:686-691.
3. Feldman AL, Libutti SK, Pingpank JF, et al.: Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 2003;21:4560-4567.
4. Verwaal VJ, van Ruth S, de Bree E, et al.: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer [see comment]. J Clin Oncol 2003;21:3737-3743.
5. Glehen O, Kwiatkowski F, Sugarbaker PH, et al.: Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 2004; 22:3284-3292.
6. Armstrong DK, Bundy B, Wenzel L, et al.: Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006; 354:34-43.
7. Glehen O, Mithieux F, Osinsky D, et al.: Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: A phase II study. J Clin Oncol 2003;21:799-806.
8. Pilati P, Mocellin S, Rossi CR, et al.: Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 2003;10:508-513.
9. Schneebaum S, Arnold MW, Staubus A, et al.: Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases. Ann Surg Oncol 1996;3:44-50.
10. Shen P, Hawksworth J, Lovato J, et al.: Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 2004;11:178-186.
11. Elias D, Pocard M, Sideris L, et al.: Preliminary results of intraperitoneal chemohyperthermia with oxaliplatin in peritoneal carcinomatosis of colorectal origin. Br J Surg 2004;91:455-456.
12. Esquivel J, Vidal-Jove J, Steves MA, et al.: Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. Surgery 1993;113:631-636.
13. Sugarbaker PH, Jablonski KA: Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995;221:124-132.
14. Jacquet P, Stephens AD, Averbach AM, et al.: Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996;77:2622-2629.
15. Stephens AD, Alderman R, Chang D, et al.: Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999;6:790-796.
16. Elias D, Blot F, El Otmany A, et al.: Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001;92:71-76.
17. Moran BJ, Mukherjee A, Sexton R: Operability and early outcome in 100 consecutive laparotomies for peritoneal malignancy. Br J Surg 2006;93:100-104.
18. Smeenk RM, Verwaal VJ, Zoetmulder FAN: Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei - a report of 103 procedures. Eur J Surg Oncol 2006;32:186-190.
19. Verwaal VJ, van Tinteren H, Ruth SV, et al.: Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004;85:61-67.
20. Ahmad SA, Kim J, Sussman JJ, et al.: Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion. Ann Surg Oncol 2004;11:387-392.
21. Glehen O, Osinsky D, Cotte E, et al.: Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: Morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 2003;10:863-869.
22. Younan R, Kusamura S, Baratti D, et al.: Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2005;12:910-918.
23. Kusamura S, Younan R, Baratti D, et al.: Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: Analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 2006;106:1144-1153.
24. Sugarbaker PH, Alderman R, Edwards G, et al.: Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 2006;13:635-644.
25. Yan TD, Alderman R, Edwards G, et al.: Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma - a prospective study of 70 consecutive cases. Ann Surg Oncol. DOI:10.1245/S/0434-006-9187-5
26. Sugarbaker PH: Peritonectomy procedures. Ann Surg 1995;221:29-42.
27. Sugarbaker PH: Dissection by electrocautery with a ball tip. J Surg Oncol 1994;56:246-248.
28. Glehen O, Gilly FN: Quantitative prognostic indicators of peritoneal surface malignancy: Carcinomatosis, sarcomatosis, and peritoneal mesothelioma. Surg Oncol Clin N Am 2003;12:649-671.
29. Sugarbaker P: Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery, 3rd edition. Michigan: The Ludann Company, Grand Rapids; 1998.